Roth Capital lowered the firm’s price target on Ceragon Networks (CRNT) to $3.75 from $4 and keeps a Buy rating on the shares. The company reported “disappointing” Q2 results as key customer in India faced continued headwinds, the analyst tells investors in a research note. The firm lowered second half of 2025 estimates for Ceragon but believes this is the sales trough. The company’s North America and private networks are well positioned for 2026, contends Roth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNT:
- Ceragon Networks Reports Q2 2025 Financial Results Amid Strategic Growth
- Ceragon Networks sees second half of FY25 revenue consistent with first half
- Ceragon Networks reports Q2 non-GAAP EPS 3c, consensus 3c
- Is CRNT a Buy, Before Earnings?
- Ceragon Networks to Release Q2 2025 Financial Results on August 6